Fulgent Agrees to Buy Texas Testing Firm Inform Diagnostics for $170M, boosting its non-Covid testing business.
In just over two years, Temple City-based Fulgent Genetics Inc. has grown from a modest genetic testing company with $32 million in annual revenue to a behemoth with nearly $1 billion in revenue last year, all because of massive Covid testing contracts. But all along, one question persisted: What happens when the Covid wave subsides?On […]








